The relationship of Prohepcidin levels with anemia and inflammatory markers in non-diabetic uremic patients: A controlled study

Renal Failure

Volumn 36, Issue 8, 2014, Pages 1253-1257

  Aydin, Zeki ^a   Gursu, Meltem ^a   Karadag, Serhat ^a   Uzun, Sami ^a   Sumnu, Abdullah ^a   Doventas, Yasemin ^a   Ozturk, Savas ^a   Kazancioglu, Rumeyza ^b  

^a HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b BEZMIALEM VAKIF UNIVERSITY   (Turkey)

Author keywords

Hemodialysis; Inflammation; Iron; Peritoneal dialysis; Prohepcidin

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CREATININE; FERRITIN; FIBRINOGEN; HEMOGLOBIN; INTERLEUKIN 6; IRON; PARATHYROID HORMONE; PHOSPHORUS; PROHEPCIDIN; UREA; BIOLOGICAL MARKER; HEPCIDIN;

ADULT; ANEMIA; ARTICLE; BLOOD CELL COUNT; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE CLEARANCE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HEMATOCRIT; HEMODIALYSIS; HUMAN; HUMAN TISSUE; INFLAMMATION; IRON BINDING CAPACITY; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RENAL REPLACEMENT THERAPY; TREATMENT DURATION; UREMIA; BLOOD; CASE CONTROL STUDY; COMPLICATION; DIABETES MELLITUS; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC;

ANEMIA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HEPCIDINS; HUMANS; INFLAMMATION; IRON; MALE; MIDDLE AGED; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; UREMIA;

EID: 84906670592     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2014.937663     Document Type: Article

References (15)

1. Kazmi WH, Kausz AT, Khan S, et al. Anemia: An early complication of chronic renal insufficiency. Am J Kidney Dis. 2001;38:803-812.
2. Ganz T. Hepcidin- A regulator of intestinal iron absorption and iron recycling by macrophages. Best Prac Res Clin Hematol. 2005; 18(2):171-182.
3. Atanasiu V, Manolescu B, Stoian I. Hepcidin-central regulator of iron metabolism. Eur J Hematol. 2007;78:1-10.
4. Taes YE, Wuyts B, Boelaert JR, De Vriese AS, Delanghe JR. Prohepcidin accumulates in renal insufficiency. Clin Chem Lab Med. 2004;42:387-389.
5. Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M. Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis. Am J Hematol. 2006;81:832-7.
6. Troutt JS, Butterfield AM, Konrad RJ. Hepcidin-25 concentrations are markedly increased in patients with chronic kidney disease and are inversely correlated with estimated glomerular filtration rates. J Clin Lab Anal. 2013;27:504-510.
7. Peters HP, Laarakkers CM, Pickkers P, et al. Tubular reabsorption and local production of urine hepcidin-25. BMC Nephrol. 2013;14: 70.
8. Malyszko J, Malyszko JS, Mysliwiec M. Serum Prohepcidin and hepcidin in hemodialyzed patients undergoing iron therapy. Kidney Blood Press Res. 2009;32:235-238.
9. Nakanishi T, KuraganoT, Kaibe S, Nagasawa Y, Hasuike Y. Should we reconsider iron administration based on prevailing ferritin and hepcidin concentrations? Clin Exp Nephrol. 2012;16:819-826.
10. Zaritsky J, Young B, Wang HJ, et al. Hepcidin- A potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol. 2009;4:1051-10516.
11. Kato A, Tsuji T, Luo J, Sakao Y, Yasuda H, Hishida A. Association of Prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients. Am J Nephrol. 2008;28:115-121.
12. Swinkels DW, Wetzels JF. Hepcidin: A new tool in the management of anaemia in patients with chronic kidney disease? Nephrol Dial Transplant. 2008;23:2450-2453.
13. Canavesi E, Alfieri C, Pelusi S, Valenti L. Hepcidin and HFE protein: Iron metabolism as a target for the anemia of chronic kidney disease. World J Nephrol. 2012;1:166-176.
14. Xue D, He X, Zhou C. Serum hepcidin level correlates with hyperlipidemia status in patients following allograft renal transplantation. Transplant Proc. 2014;46:156-159.
15. Samouilidou E, Pantelias K, Petras D, et al. Serum Hepcidin Levels Are Associated With Serum Triglycerides and Interleukin-6 Concentrations in Patients With End-Stage Renal Disease. Ther Apher Dial. 2014;18:279-283.